Literature DB >> 23603787

The specification of telencephalic glutamatergic neurons from human pluripotent stem cells.

Erin M Boisvert1, Kyle Denton, Ling Lei, Xue-Jun Li.   

Abstract

Here, a stepwise procedure for efficiently generating telencephalic glutamatergic neurons from human pluripotent stem cells (PSCs) has been described. The differentiation process is initiated by breaking the human PSCs into clumps which round up to form aggregates when the cells are placed in a suspension culture. The aggregates are then grown in hESC medium from days 1-4 to allow for spontaneous differentiation. During this time, the cells have the capacity to become any of the three germ layers. From days 5-8, the cells are placed in a neural induction medium to push them into the neural lineage. Around day 8, the cells are allowed to attach onto 6 well plates and differentiate during which time the neuroepithelial cells form. These neuroepithelial cells can be isolated at day 17. The cells can then be kept as neurospheres until they are ready to be plated onto coverslips. Using a basic medium without any caudalizing factors, neuroepithelial cells are specified into telencephalic precursors, which can then be further differentiated into dorsal telencephalic progenitors and glutamatergic neurons efficiently. Overall, our system provides a tool to generate human glutamatergic neurons for researchers to study the development of these neurons and the diseases which affect them.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23603787      PMCID: PMC3656538          DOI: 10.3791/50321

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  44 in total

1.  Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes.

Authors:  Stormy J Chamberlain; Pin-Fang Chen; Khong Y Ng; Fany Bourgois-Rocha; Fouad Lemtiri-Chlieh; Eric S Levine; Marc Lalande
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

2.  Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors.

Authors:  Wenlin Li; Wei Wei; Saiyong Zhu; Jinliang Zhu; Yan Shi; Tongxiang Lin; Ergeng Hao; Alberto Hayek; Hongkui Deng; Sheng Ding
Journal:  Cell Stem Cell       Date:  2008-12-18       Impact factor: 24.633

3.  Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice.

Authors:  Lixiang Ma; Baoyang Hu; Yan Liu; Scott Christopher Vermilyea; Huisheng Liu; Lu Gao; Yan Sun; Xiaoqing Zhang; Su-Chun Zhang
Journal:  Cell Stem Cell       Date:  2012-03-15       Impact factor: 24.633

4.  Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

Authors:  Neeta S Roy; Carine Cleren; Shashi K Singh; Lichuan Yang; M Flint Beal; Steven A Goldman
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

5.  Neural progenitors from human embryonic stem cells.

Authors:  B E Reubinoff; P Itsykson; T Turetsky; M F Pera; E Reinhartz; A Itzik; T Ben-Hur
Journal:  Nat Biotechnol       Date:  2001-12       Impact factor: 54.908

6.  Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity.

Authors:  Dae-Sung Kim; Jae Souk Lee; Joong Woo Leem; Yong Jun Huh; Ji Young Kim; Han-Soo Kim; In-Hyun Park; George Q Daley; Dong-Youn Hwang; Dong-Wook Kim
Journal:  Stem Cell Rev Rep       Date:  2010-06       Impact factor: 5.739

7.  Specification of motoneurons from human embryonic stem cells.

Authors:  Xue-Jun Li; Zhong-Wei Du; Ewa D Zarnowska; Matthew Pankratz; Lauren O Hansen; Robert A Pearce; Su-Chun Zhang
Journal:  Nat Biotechnol       Date:  2005-01-30       Impact factor: 54.908

8.  Generation of human induced pluripotent stem cells from dermal fibroblasts.

Authors:  W E Lowry; L Richter; R Yachechko; A D Pyle; J Tchieu; R Sridharan; A T Clark; K Plath
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-15       Impact factor: 11.205

9.  Induced pluripotent stem cells from a spinal muscular atrophy patient.

Authors:  Allison D Ebert; Junying Yu; Ferrill F Rose; Virginia B Mattis; Christian L Lorson; James A Thomson; Clive N Svendsen
Journal:  Nature       Date:  2008-12-21       Impact factor: 49.962

10.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

View more
  15 in total

1.  Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia.

Authors:  Kyle R Denton; Ling Lei; Jeremy Grenier; Vladimir Rodionov; Craig Blackstone; Xue-Jun Li
Journal:  Stem Cells       Date:  2014-02       Impact factor: 6.277

2.  ADAR1 is required for differentiation and neural induction by regulating microRNA processing in a catalytically independent manner.

Authors:  Tian Chen; Jian-Feng Xiang; Shanshan Zhu; Siye Chen; Qing-Fei Yin; Xiao-Ou Zhang; Jun Zhang; Hua Feng; Rui Dong; Xue-Jun Li; Li Yang; Ling-Ling Chen
Journal:  Cell Res       Date:  2015-02-24       Impact factor: 25.617

3.  Idiopathic Autism: Cellular and Molecular Phenotypes in Pluripotent Stem Cell-Derived Neurons.

Authors:  Xiaozhuo Liu; Emilie Campanac; Hoi-Hung Cheung; Mark N Ziats; Lucile Canterel-Thouennon; Margarita Raygada; Vanessa Baxendale; Alan Lap-Yin Pang; Lu Yang; Susan Swedo; Audrey Thurm; Tin-Lap Lee; Kwok-Pui Fung; Wai-Yee Chan; Dax A Hoffman; Owen M Rennert
Journal:  Mol Neurobiol       Date:  2016-06-29       Impact factor: 5.590

4.  Pharmacologic rescue of axon growth defects in a human iPSC model of hereditary spastic paraplegia SPG3A.

Authors:  Peng-Peng Zhu; Kyle R Denton; Tyler Mark Pierson; Xue-Jun Li; Craig Blackstone
Journal:  Hum Mol Genet       Date:  2014-06-06       Impact factor: 6.150

Review 5.  Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism.

Authors:  Sabine Jung-Klawitter; Thomas Opladen
Journal:  J Inherit Metab Dis       Date:  2018-07-06       Impact factor: 4.982

6.  Impaired mitochondrial dynamics underlie axonal defects in hereditary spastic paraplegias.

Authors:  Kyle Denton; Yongchao Mou; Chong-Chong Xu; Dhruvi Shah; Jaerak Chang; Craig Blackstone; Xue-Jun Li
Journal:  Hum Mol Genet       Date:  2018-07-15       Impact factor: 6.150

7.  Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia.

Authors:  Yongchao Mou; Sukhada Mukte; Eric Chai; Joshua Dein; Xue-Jun Li
Journal:  J Vis Exp       Date:  2020-02-09       Impact factor: 1.355

Review 8.  Induced pluripotent stem cells as a discovery tool for Alzheimer׳s disease.

Authors:  Sarah E Sullivan; Tracy L Young-Pearse
Journal:  Brain Res       Date:  2015-10-13       Impact factor: 3.252

9.  Monitoring Axonal Degeneration in Human Pluripotent Stem Cell Models of Hereditary Spastic Paraplegias.

Authors:  Xue-Jun Li; Yongchao Mou; Conrad Milton; Zhenyu Chen
Journal:  Methods Mol Biol       Date:  2022

10.  The Specification and Maturation of Nociceptive Neurons from Human Embryonic Stem Cells.

Authors:  Erin M Boisvert; Sandra J Engle; Shawn E Hallowell; Ping Liu; Zhao-Wen Wang; Xue-Jun Li
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.